Gilead expands hepatitis C generic licensing agreements to include investigational pan-genotypic agent [Internet]
Author(s):
Publication date: 2015
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.